Natalie S. Grover
-
- Lymphoma Diagnosis and Treatment 44
- Oncology top 10%
- CAR-T cell therapy research 37
- Viral-associated cancers and disorders 10
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 9
- Reproductive Medicine top 10%
-
- CNS Lymphoma Diagnosis and Treatment 10
-
- Biosimilars and Bioanalytical Methods 7
-
- Cutaneous lymphoproliferative disorders research 6
-
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Barbara SavoldoGianpietro DottiSteven ParkAnastasia IvanovaJennifer E. MersereauChristopher DittusAllison M. DealJonathan S. Serody
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Natalie S. Grover
69 papers receiving 647 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 296
- Oncology 439
- Genetics 86
- Reproductive Medicine 53
- Neurology 76
Countries citing papers authored by Natalie S. Grover
This map shows the geographic impact of Natalie S. Grover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie S. Grover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie S. Grover more than expected).
Fields of papers citing papers by Natalie S. Grover
This network shows the impact of papers produced by Natalie S. Grover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie S. Grover. The network helps show where Natalie S. Grover may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Natalie S. Grover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 28 | |
| 18 | 2018 | 34 | |
| 19 | 2017 | 4 | |
| 20 | 2011 | 7 |
About Natalie S. Grover
Natalie S. Grover is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 80 papers that have together received 653 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), CAR-T cell therapy research (37 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Biosimilars and Bioanalytical Methods (7 papers), Cutaneous lymphoproliferative disorders research (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (296 citations), Oncology (439 citations) and Genetics (86 citations). Natalie S. Grover has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Barbara Savoldo, Gianpietro Dotti, Steven Park, Anastasia Ivanova, Jennifer E. Mersereau, Christopher Dittus, Allison M. Deal, Jonathan S. Serody, Catherine Cheng and Anne Beaven.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.